52 related articles for article (PubMed ID: 38734621)
1. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract][Full Text] [Related]
2.
Brock P; Sevigny M; Liyanarachchi S; Comiskey DF; Li W; Saarinen S; Yilmaz AS; Nieminen AI; Ringel MD; Peltomäki P; Ollila S; Nieminen TT
Thyroid; 2024 May; 34(5):575-582. PubMed ID: 38062777
[No Abstract] [Full Text] [Related]
3. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract][Full Text] [Related]
4. Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC.
Nie T; Syed YY
Target Oncol; 2023 Jan; 18(1):169-176. PubMed ID: 36422787
[TBL] [Abstract][Full Text] [Related]
5.
Dadafarin S; Rodríguez TC; Carnazza MA; Tiwari RK; Moscatello A; Geliebter J
Cells; 2022 Oct; 11(19):. PubMed ID: 36231143
[TBL] [Abstract][Full Text] [Related]
6. RET kinase inhibitors for
Vodopivec DM; Hu MI
Ther Adv Med Oncol; 2022; 14():17588359221101691. PubMed ID: 35756966
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment and survivorship statistics, 2022.
Miller KD; Nogueira L; Devasia T; Mariotto AB; Yabroff KR; Jemal A; Kramer J; Siegel RL
CA Cancer J Clin; 2022 Sep; 72(5):409-436. PubMed ID: 35736631
[TBL] [Abstract][Full Text] [Related]
8. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
9. Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Ma LX; Espin-Garcia O; Bedard PL; Stockley T; Prince R; Mete O; Krzyzanowska MK
Thyroid; 2022 Jun; 32(6):657-666. PubMed ID: 35262412
[No Abstract] [Full Text] [Related]
10. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
11. Ensembl 2022.
Cunningham F; Allen JE; Allen J; Alvarez-Jarreta J; Amode MR; Armean IM; Austine-Orimoloye O; Azov AG; Barnes I; Bennett R; Berry A; Bhai J; Bignell A; Billis K; Boddu S; Brooks L; Charkhchi M; Cummins C; Da Rin Fioretto L; Davidson C; Dodiya K; Donaldson S; El Houdaigui B; El Naboulsi T; Fatima R; Giron CG; Genez T; Martinez JG; Guijarro-Clarke C; Gymer A; Hardy M; Hollis Z; Hourlier T; Hunt T; Juettemann T; Kaikala V; Kay M; Lavidas I; Le T; Lemos D; Marugán JC; Mohanan S; Mushtaq A; Naven M; Ogeh DN; Parker A; Parton A; Perry M; Piližota I; Prosovetskaia I; Sakthivel MP; Salam AIA; Schmitt BM; Schuilenburg H; Sheppard D; Pérez-Silva JG; Stark W; Steed E; Sutinen K; Sukumaran R; Sumathipala D; Suner MM; Szpak M; Thormann A; Tricomi FF; Urbina-Gómez D; Veidenberg A; Walsh TA; Walts B; Willhoft N; Winterbottom A; Wass E; Chakiachvili M; Flint B; Frankish A; Giorgetti S; Haggerty L; Hunt SE; IIsley GR; Loveland JE; Martin FJ; Moore B; Mudge JM; Muffato M; Perry E; Ruffier M; Tate J; Thybert D; Trevanion SJ; Dyer S; Harrison PW; Howe KL; Yates AD; Zerbino DR; Flicek P
Nucleic Acids Res; 2022 Jan; 50(D1):D988-D995. PubMed ID: 34791404
[TBL] [Abstract][Full Text] [Related]
12. BRAF mutations in thyroid cancer.
Scheffel RS; Dora JM; Maia AL
Curr Opin Oncol; 2022 Jan; 34(1):9-18. PubMed ID: 34636352
[TBL] [Abstract][Full Text] [Related]
13. Precision therapy for RET-altered cancers with RET inhibitors.
Thein KZ; Velcheti V; Mooers BHM; Wu J; Subbiah V
Trends Cancer; 2021 Dec; 7(12):1074-1088. PubMed ID: 34391699
[TBL] [Abstract][Full Text] [Related]
14. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
15. Intracranial Efficacy of Selpercatinib in
Subbiah V; Gainor JF; Oxnard GR; Tan DSW; Owen DH; Cho BC; Loong HH; McCoach CE; Weiss J; Kim YJ; Bazhenova L; Park K; Daga H; Besse B; Gautschi O; Rolfo C; Zhu EY; Kherani JF; Huang X; Kang S; Drilon A
Clin Cancer Res; 2021 Aug; 27(15):4160-4167. PubMed ID: 34088726
[TBL] [Abstract][Full Text] [Related]
16. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
Abe I; Lam AK
Histol Histopathol; 2021 Mar; 36(3):239-248. PubMed ID: 33170501
[TBL] [Abstract][Full Text] [Related]
18. Roles of the
Takahashi M; Kawai K; Asai N
JMA J; 2020 Jul; 3(3):175-181. PubMed ID: 33150251
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
